High-conviction investment themes across health, technology, and infrastructure — each supported by deep domain knowledge, proprietary networks, and a consistent track record of value creation.
Healthcare, life sciences, biotechnology, medical technology, and innovative care platforms at the intersection of clinical innovation and long-term structural demand.
We invest in companies with differentiated science, validated clinical evidence, and clear pathways to regulatory approval and commercial adoption. Our portfolio spans biopharmaceuticals, medical devices, surgical robotics, genomics, and care delivery innovation.
Artificial intelligence, enterprise software, digital platforms, and emerging technologies reshaping industries and creating enduring competitive advantages at scale.
We look for technology companies with proprietary platforms, strong network effects or switching costs, durable recurring revenue, and clear paths to market leadership. Differentiated technology with real-world adoption is our core criterion.
Data centers, digital infrastructure, energy, power assets, and mission-critical real assets that underpin the modern economy and generate stable, long-term returns.
We focus on infrastructure with strong demand visibility, long-term contracted revenues, high barriers to entry, and strategic positioning at the intersection of digital transformation and the global energy transition.